Dihydrocodeine and Buprenorphine: Interaction Details
AI-assisted, pharmacist-reviewed · AI content regenerated Jul 11, 2026 · Source data updated Jul 2, 2026 · Sources: FDA labeling, DDInter 2.0, cited literature
Buprenorphine
Dihydrocodeine
No brand names on record
How we grade severity & evidence
Severity levels
- Contraindicated: These should generally not be used together.
- Major: Potentially serious — often needs a change or close monitoring.
- Moderate: Can be significant — usually manageable with monitoring.
- Minor: Usually limited clinical impact.
Evidence grades
- Established: Well documented — supported by controlled studies or strong clinical data.
- Probable: Good supporting evidence, though not definitively proven.
- Suspected: Some evidence suggests this interaction, but it is not well established.
- Possible: Limited or conflicting evidence; the interaction may occur.
- Theoretical: Predicted from the drugs' pharmacology; not yet confirmed in people.
Ratings come from the documented interaction literature and are reviewed by a pharmacist. They describe the documented risk of the combination, not what will necessarily happen to you — your dose, timing, and health picture all matter.
These two pain medicines can work against each other. Buprenorphine (found in brands like Belbuca, BuTrans, and Sublocade) is a partial opioid. It grabs tightly onto the same spots in your body that dihydrocodeine uses, but only turns them on part way. So if you take both, buprenorphine can block dihydrocodeine from working. That may leave your pain poorly controlled, and if your body is used to a full opioid, it can even trigger withdrawal (things like sweating, chills, cramps, and feeling anxious).
There is also a possible added risk of serotonin syndrome when opioids that affect serotonin are combined. The good news: your care team can manage this safely. Please talk with your pharmacist or doctor before taking both.
Mechanism: Buprenorphine is a high-affinity partial mu-opioid agonist / kappa antagonist. Given with dihydrocodeine (a full agonist), competitive receptor occupancy can reduce dihydrocodeine's analgesic effect and precipitate withdrawal in opioid-dependent patients. Both agents carry serotonergic activity, so additive effects raise serotonin syndrome risk.
- Direction: reduced opioid effect + withdrawal risk; additive serotonergic risk
- Evidence: theoretical; severity major; onset unspecified
- Management: avoid combining a partial/mixed agonist-antagonist with dihydrocodeine. If serotonergic co-use is unavoidable, monitor closely during initiation/titration for hyperthermia, clonus, agitation, autonomic instability. Discontinue dihydrocodeine if serotonin syndrome is suspected.
Note: dihydrocodeine is a CYP2D6-activated prodrug, but the primary concern here is receptor-level antagonism.
What happens
Reduced analgesic effect or precipitation of withdrawal symptoms and an increased risk of serotonin syndrome
Interaction Deep Dive
Do not combine dihydrocodeine with a partial agonist opioid analgesic or a mixed opioid agonist/antagonist, because doing so may diminish the analgesic effect of dihydrocodeine and could trigger withdrawal symptoms. Furthermore, monitor the patient closely when dihydrocodeine is given alongside other agents that act on the serotonergic system, particularly at the start of therapy and during dose titration, since the likelihood of serotonin syndrome rises. If serotonin syndrome is suspected, stop dihydrocodeine1.
Why it happens (mechanism)
Opioid receptor antagonism; additive serotonergic effects
How to manage this interaction
The main step here is usually avoiding this combination. Because buprenorphine can block dihydrocodeine and even bring on withdrawal, most care teams will not use these two full pain opioids together and will choose one approach instead.
- Keep taking your medicines as prescribed and do not start, stop, or change either one on your own.
- Tell your pharmacist or prescriber that you take (or were offered) both, so they can pick the safest single plan for your pain.
- Watch for withdrawal (sweating, chills, cramps, anxiety) or serotonin syndrome (agitation, fast heart rate, shivering, muscle twitching, fever), especially when a dose is started or increased, and get help promptly if these appear.
Management is individual — confirm any change with your pharmacist or prescriber.
Literature reports
1 report — tap to read
a) Instances of serotonin syndrome, a condition that can be life-threatening, have been documented when opioids are used together with serotonergic agents 1.
Common questions
Can I take Dihydrocodeine and Buprenorphine together?
Buprenorphine can block dihydrocodeine from relieving pain and may trigger opioid withdrawal, plus there is an added serotonin syndrome risk, so this pairing is generally avoided. Talk to your pharmacist or doctor before using both. Always confirm with your pharmacist or prescriber before making any change.
How serious is the Dihydrocodeine and Buprenorphine interaction?
It is rated major. Potentially serious — often needs a change or close monitoring.
How quickly could this interaction happen?
The documented onset is "unspecified". The timing of this interaction is not well characterized.
How is the Dihydrocodeine and Buprenorphine interaction managed?
The main step here is usually avoiding this combination. Because buprenorphine can block dihydrocodeine and even bring on withdrawal, most care teams will not use these two full pain opioids together and will choose one approach instead. Keep taking your medicines as prescribed and do not start, stop, or change either one on your own. Tell your pharmacist or prescriber that you take (or were offer… Management is individual — always follow your own care team's guidance.
How strong is the evidence for this interaction?
The evidence is graded "theoretical". Predicted from the drugs' pharmacology; not yet confirmed in people.
Questions for your pharmacist
- Does my dose of Dihydrocodeine or Buprenorphine need adjusting while I take them together?
- What symptoms should prompt me to call you or my prescriber right away?
- Does the timing of my doses matter for this combination?
- Is there a safer alternative to one of these medications for me?
References (1)
- Product Information: SYNALGOS(R)-DC oral capsules, aspirin, caffeine, dihydrocodeine bitartrate oral capsules. Sun Pharmaceuticals Industries Inc (per FDA), Cranbury, NJ, 2023. DailyMed
Keep reading about Buprenorphine
Keep reading about Dihydrocodeine
These medications also interact with supplements
Prescription drugs aren't the whole picture — herbal and dietary supplements can interact with them too. From the evidence-graded Natural Medicines database:
major · moderate · minor — check everything you take with our drug–supplement interaction checker.
Check another combination
Our instant two-drug interaction checker is almost here.
Still have questions about this combination?
Every question gets a real answer from a licensed pharmacist — free, and usually within a day.
Ask the pharmacist